We now offer extended release buprenorphine injections Sublocade and Brixadi. What is the difference between Sublocade and Brixadi? Sublocade and Brixadi are both long-acting subcutaneous (SC) (under the skin) buprenorphine injections that may be used for the maintenance treatment of opioid misuse disorder in adults. Sublocade was approved on November 30, 2017, and Brixadi was approved on May … Continue reading BUPRENORPHINE INJECTIONS